Weed stocks: A growing industry
Should you invest in weed stocks? Take a look and see what can help your portfolio grow.
Photo: National Cancer Institute / Unsplash
Mid-weight oncology stocks: The dark horses of cancer research
18 symbolsUpdated
The oncology industry is vast and has many layers. While big names like Bristol Myers Squibb and Pfizer are dedicating a plethora of resources to defeat cancer, lesser known companies are equally out there trying to treat and prevent the disease. These companies are often involved in within the pharmaceutical and bio industries, with growth stemming from investment and revenues from their various ventures.
This Spark contains some of these middleweight firms involved in cancer research or treatment in the US, with a market cap of between 300m and 2bn. For bigger companies, we have you covered with our other curated list, and we've got your back for the smaller guys too. But don't rely on these lists alone. This isn't advice, so make sure you do your own research.
This Spark contains some of these middleweight firms involved in cancer research or treatment in the US, with a market cap of between 300m and 2bn. For bigger companies, we have you covered with our other curated list, and we've got your back for the smaller guys too. But don't rely on these lists alone. This isn't advice, so make sure you do your own research.
News
No news today
Turns out there's no information yet on the latest world events
Related sparks
Biotech stocks: A shot in the arm
Though most would happily forget the 2020 pandemic, these biotech stocks have gotten a shot in the arm.
Low-cap oncology stocks: Small companies fighting cancer
Cancer research has come a long way, and now smaller operations are seeking innovative methods to tackle the disease.
Big pharma stocks: Top pharmaceutical firms
These giants of the drugs world were in focus during the global pandemic, but there's much more to this multi-billion dollar industry than just vaccines.
Cancer research stocks: Oncology pharmaceutical market
Cancer research and drugs manufacture is a vital – but costly – enterprise.
Covid vaccine stocks: Jabtastic
COVID-19 happened, and then the whole world needed a jab. Meet the vaccine makers who've profited the most.